Control of telomere length by the human telomeric protein TRF1
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Human telomeres, the nucleoprotein complexes at chromosome ends, consist of tandem arrays of TTAGGG repeats bound to specific proteins. In normal human cells, telomeres shorten with successive cell divisions, probably due to the terminal sequence loss that accompanies DNA replication. In tumours and immortalized cells, this decline is halted through the activation of telomerase, a reverse transcriptase that extends the telomeric TTAGGG-repeat arrays. Telomere length is stable in several immortal human-cell lines, suggesting that a regulatory mechanism exists for limiting telomere elongation by telomerase. Here we show that the human telomeric-repeat binding factor TRF1 (ref. 8) is involved in this regulation. Long-term overexpression of TRF1 in the telomerase-positive tumour-cell line HT1080 resulted in a gradual and progressive telomere shortening. Conversely, telomere elongation was induced by expression of a dominant-negative TRF1 mutant that inhibited binding of endogenous TRF1 to telomeres. Our results identify TRF1 as a suppressor of telomere elongation and indicate that TRF1 is involved in the negative feedback mechanism that stabilizes telomere length. As TRF1 does not detectably affect the expression of telomerase, we propose that the binding of TRF1 controls telomere length in cis by inhibiting the action of telomerase at the ends of individual telomeres.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TRF1 can serve to modulate telomere length, but it also serves to facilitate DNA replication through the telomere repeats, which acts as fragile DNA sites (5)(6)(7).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [5]
In the citing paper
“TRF1 and TRF2 bind the double-stranded telomere.”
From Telomeres and telomerase in cancer (2010) · cites this paper as van Steensel,B. et al. (1997)
In the citing paper
“Telomere length in human cells is controlled by a homeostasis mechanism that involves telomerase and the negative regulator of telomere length, TRF1 (TTAGGG repeat binding factor 1).”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“In this system, TRF1 did not affect the activity of telomerase detectable in cell extracts, suggesting that TRF1 does not affect telomerase activity globally in the cell.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“Conversely, the expression of a dominant negative allele of TRF1, which removes endogenous TRF1 from telomeres, leads to telomere elongation.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Progress towards a quantitative understanding of Antarctic ozone depletion
Solomon, S. (1990) · Nature · doi:10.1038/347347a0 · Cited by 734
Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., & de Lange, T. (1995) · Science · doi:10.1126/science.270.5242.1663 · Cited by 694
Cited by
Items 501–600 of 1,000
D‐galactose‐induced cardiac ageing: A review of model establishment and potential interventions
Wang, S.-S., Zhang, X., Ke, Z., Wen, X., Li, W., Liu, W., Zhuang, X., & Liao, L. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17580 · Cited by 55
Liu, S., Nong, W., Ji, L., Zhuge, X., Wei, H., Luo, M., Zhou, L., Chen, S., Zhang, S., Lei, X., et al. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112132 · Cited by 54
Soohoo, C., Shi, R., Lee, T. H., Huang, P., Lu, K. P., & Zhou, X. Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180174 · Cited by 58
A novel form of the telomere-associated protein TIN2 localizes to the nuclear matrix
Kaminker, P. G., Kim, S., Desprez, P., & Campisi, J. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7941 · Cited by 59
Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas
Takagi, S., Kinouchi, Y., Hiwatashi, N., Chida, M., Nagashima, F., Takahashi, S., Negoro, K., Shimosegawa, T., & Toyota, T. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991015)86:8<1431::aid-cncr7>3.0.co;2-r · Cited by 47
Wu, Y., Zacal, N., Rainbow, A. J., & Zhu, X. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.09.005 · Cited by 53
Kaminker, P. G., Plachot, C., Kim, S., Chung, P. W. M., Crippen, D., Petersen, O. W., Bissell, M. J., Campisi, J., & Lelièvre, S. A. (2005) · Journal of Cell Science · doi:10.1242/jcs.01709 · Cited by 47
“In mammalian cells, the telomeric end structure is controlled by several telomereassociated proteins, including TRF1, TRF2 and TIN2 (van Steensel and de Lange, 1997; Kim et al., 1999; Kim et al., 2003a).”
BackgroundLife and cancer without telomerase: ALT and other strategies for making sure ends (don’t) meet
Apte, M. S., & Cooper, J. P. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1260090 · Cited by 47
Cai, Y., Kandula, V., Kosuru, R., Ye, X., Irwin, M. G., & Xia, Z. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1371886 · Cited by 49
Telomeres And Telomerase in Adult Stem Cells and Pluripotent Embryonic Stem Cells
Marión, R. M., & Blasco, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_9 · Cited by 52
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems
Serene, R. L. (2005) · Frontiers in bioscience · doi:10.2741/1661 · Cited by 50
“resulting in telomere extension by telomerase (63).”
Persistent telomere cohesion triggers a prolonged anaphase
Kim, M. K., & Smith, S. H. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-08-0479 · Cited by 45
Non-canonical roles of canonical telomere binding proteins in cancers
Akıncılar, S. C., Chan, C. H. T., Ng, Q. F., Fidan, K., & Tergaonkar, V. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03783-0 · Cited by 47
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer
Yu, M., Yang, Y., Sykes, M. J., & Wang, S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02139 · Cited by 46
Protection against chromosome degradation at the telomeres
Grandin, N., & Charbonneau, M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.008 · Cited by 49
Distinct Functions of POT1 at Telomeres
Barrientos, K. S., Kendellen, M. F., Freibaum, B. D., Armbruster, B. N., Etheridge, K. T., & Counter, C. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00048-08 · Cited by 53
“The protein portion of telomeres is composed of two telomeric dsDNA-binding proteins, TRF1 and TRF2 (6, 25, 42, 46, 47), and one telomeric ssDNA-binding protein, POT1 (4, 5), which form a large complex, mediated by proteins such as TIN2 and TPP1 (24, 26, 28, 30, 31, 39, 56, 57), that maintains chromosome end stability…”
BackgroundCritically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes
Swiggers, S. J. J., Kuijpers, M. A., de Cort, M. J., Beverloo, H. B., & Zijlmans, J. M. J. M. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20286 · Cited by 50
Genome stability from the perspective of telomere length
Lu, X., & Liu, L. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.10.013 · Cited by 50
Targeting the telosome: Therapeutic implications
Folini, M., Gandellini, P., & Zaffaroni, N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.014 · Cited by 46
Multiple POT1–TPP1 Proteins Coat and Compact Long Telomeric Single-Stranded DNA
Taylor, D. J., Podell, E. R., Taatjes, D. J., & Cech, T. R. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.049 · Cited by 51
Yang, S. W., Kim, S. K., & Kim, W. T. (2004) · The Plant Cell · doi:10.1105/tpc.104.026278 · Cited by 44
Nakamura, M., Nabetani, A., Mizuno, T., Hanaoka, F., & Ishikawa, F. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11073-11088.2005 · Cited by 43
“binding proteins (TRF1 in vertebrates) (41, 62).”
Grossi, S., Bianchi, A., Damay, P., & Shore, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8117-8128.2001 · Cited by 44
“repeat binding proteins (34, 46, 50, 54) that is likely to act in cis”
BackgroundKim, M. K., Kang, M. R., Nam, H. W., Bae, Y., Kim, Y. S., & Chung, I. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710065200 · Cited by 50
Yasui, W., Tahara, E., Tahara, H., Fujimoto, J., Naka, K., Nakayama, J., Ishikawa, F., Ide, T., & 田原, 榮. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00787.x · Cited by 51
Telomerase: biology and phase I trials
Kèlland, L. R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00226-6 · Cited by 47
A beginning of the end: new insights into the functional organization of telomeres
Wood, A. M., Laster, K., Rice, E. L., & Kosak, S. T. (2015) · Nucleus · doi:10.1080/19491034.2015.1048407 · Cited by 42
Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients
Joksic, I., Vujic, D., Guc-Scekic, M., Leskovac, A., Petrovic, S., Ojani, M., Trujillo, J. P., Surralles, J., Zivkovic, M., Stankovic, A., et al. (2012) · Genome Integrity · doi:10.1186/2041-9414-3-6 · Cited by 40
Fernandes, S. G., Dsouza, R., & Khattar, E. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103633 · Cited by 47
Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse
Remes, K., Norrback, K.-F., Rosenquist, R., Mehle, C., Lindh, J., & Roos, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0970 · Cited by 47
Trujillo, K. M., Bunch, J. T., & Baumann, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414511200 · Cited by 43
Nakanishi, K., Kawai, T., Kumaki, F., Hirot, S., Mukai, M., & Ikeda, E. (2002) · Human Pathology · doi:10.1053/hupa.2002.125775 · Cited by 45
Accelerated telomere shortening in bonemarrow recipients
Shay, J. W. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78218-0 · Cited by 43
POT1 recruits and regulates CST-Polα/primase at human telomeres
Cai, S. W., Takai, H., Zaug, A. J., Dilgen, T. C., Cech, T. R., Walz, T., & de Lange, T. (2024) · Cell · doi:10.1016/j.cell.2024.05.002 · Cited by 45
́Alcontres, M. S. D., Palacios, A., Mejias, D., & Blasco, M. A. (2014) · Cell Cycle · doi:10.4161/cc.28419 · Cited by 42
“TRF1 has been shown to lead to telomere shortening when overexpressed, whereas its inhibition by a dominant-negative form caused telomere elongation.(8) Ubiquitous deletion of the Trf1 gene in mice results in early embryonic lethality,(9) and ES cells conditionally deleted for TRF1 showed increased chromosomal aberrat…”
BackgroundTelomere length and telomerase activity during folliculogenesis in mammals
Kosebent, E. G., Uysal, F., & Öztürk, S. (2018) · Journal of Reproduction and Development · doi:10.1262/jrd.2018-076 · Cited by 43
SIRT6 participates in the quality control of aged oocytes via modulating telomere function
Ge, J., Li, C., Li, C., Huang, Z., Zeng, J., Han, L., & Wang, Q. (2019) · Aging · doi:10.18632/aging.101885 · Cited by 43
“TRF1 blocks telomerase access to the telomeres, and overexpression of TRF1 induces a gradual decline in telomere length [22, 23].”
BackgroundSperry, J. B., Shi, X. E., Rempel, D. L., Nishimura, Y., Akashi, S., & Gross, M. L. (2008) · Biochemistry · doi:10.1021/bi702037p · Cited by 42
McKerlie, M., Lin, S., & Zhu, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks035 · Cited by 51
“Blotting for telomeric fragments was carried out according to standard protocols (15).”
MethodNot so peculiar: fission yeast telomere repeats
Hiraoka, Y., Henderson, E. R., & Blackburn, E. H. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01176-1 · Cited by 42
T Cell Renewal Rates, Telomerase, and Telomere Length Shortening
de Boer, R. J., & Noest, A. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5832 · Cited by 46
“In tumor cells, additional factors have recently been described, such as the telomeric repeat-binding factor TRF1 (31), which are involved in repairing telomere shortening dependent on the telomere length.”
Recent advances in the development of telomerase inhibitors for the treatment of cancer
Perry, P. J., & Jenkins, T. C. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.1981 · Cited by 43
Villa, R., Porta, C. D., Folini, M., Daidone, M. G., & Zaffaroni, N. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01343.x · Cited by 45
Jehi, S. E., Li, X., Sandhu, R. S., Ye, F., Benmerzouga, I., Zhang, M., Zhao, Y., & Li, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku942 · Cited by 45
Transcription regulates telomere dynamics in human cancer cells
Arora, R., Brun, C. M., & Azzalin, C. M. (2012) · RNA · doi:10.1261/rna.029587.111 · Cited by 47
Tripathi, E., & Smith, S. H. (2016) · The EMBO Journal · doi:10.15252/embj.201695135 · Cited by 42
Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis
Lantuéjoul, S., Raynaud, C. M., Salameire, D., Gazzéri, S., Moro‐Sibilot, D., Soria, J., Brambilla, C., & Brambilla, E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0142 · Cited by 47
“Nevertheless, TRF1 acts with tankyrase 1 and 2 to control telomere access in order to decrease the possibility of a further elongation by telomerase (28) and is thus considered as a negative regulator of telomere elongation; however, it is upregulated through a negative feedback loop when telomerase is activated, its…”
BackgroundCharacterization of the DNA binding specificity of Shelterin complexes
Choi, K. H., Farrell, A. S., Lakamp, A. S., & Ouellette, M. M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr665 · Cited by 47
Detection of telomerase activity in oral lesions
Sumida, T., Sogawa, K., Hamakawa, H., Sugita, A., Tanioka, H., & Ueda, N. (1998) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1998.tb01925.x · Cited by 41
Telomerase-Independent Stabilization of Short Telomeres in Trypanosoma brucei
Dreesen, O., & Cross, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00212-06 · Cited by 47
“The ability of telomerase to extend a telomere is inversely proportional to the initial length of the telomere DNA repeats (36, 37, 56).”
BackgroundTRF1 Ensures the Centromeric Function of Aurora-B and Proper Chromosome Segregation
Ohishi, T., Muramatsu, Y., Yoshida, H., & Seimiya, H. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00161-14 · Cited by 43
“TRF1 directly binds doublestranded telomeric DNA (TTAGGG repeats) and negatively regulates telomere length (5).”
BackgroundA novel yeast cell-based screen identifies flavone as a tankyrase inhibitor
Yashiroda, Y., Okamoto, R., Hatsugai, K., Takemoto, Y., Goshima, N., Saito, T., Hamamoto, M., Sugimoto, Y., Osada, H., Seimiya, H., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.021 · Cited by 40
The Emerging Role of Telomerase in Cardiac Muscle Cell Growth and Survival
Oh, H., & Schneider, M. D. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2018 · Cited by 41
Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience
Gelmini, S., Quattrone, S., Malentacchi, F., Villari, D., Travaglini, F., Giannarini, G., Melina, A. D., Pazzagli, M., Nicita, G., Selli, C., et al. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.133 · Cited by 41
Telomere maintenance and length regulation in Trypanosoma brucei
Horn, D., Spence, C., & Ingram, A. K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.10.2332 · Cited by 40
Telomerase enzyme activation and human cell immortalization
Meyerson, M. M. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00278-1 · Cited by 42
Hu, B. T., & Insel, R. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3745::aid-immu3745>3.0.co;2-1 · Cited by 42
Homogeneous tetracycline-regulatable gene expression in mammalian fibroblasts
Izumi, M., & Gilbert, D. M. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000201)76:2<290::aid-jcb12>3.0.co;2-v · Cited by 40
Telomerase inhibitors: targeting the vulnerable end of cancer?
Kèlland, L. R. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200008000-00001 · Cited by 43
“Long-term overexpression of TRF1 resulted in progressive telomere shortening while, conversely, expression of a dominant-negative TRF1 mutant caused telomere elongation.(23) Another protein, TRF2 (telomeric repeat binding factor 2), protects human telomeres from end-to-end fusions,(25) possibly through the remodeling…”
BackgroundPersistent telomere cohesion protects aged cells from premature senescence
Azarm, K., Bhardwaj, A., Kim, E., & Smith, S. (2020) · Nature Communications · doi:10.1038/s41467-020-17133-4 · Cited by 35
The Connection Between Cell Fate and Telomere
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_3 · Cited by 41
Telomere uncapping during in vitro T‐lymphocyte senescence
Chebel, A., Bauwens, S., Gerland, L., Belleville, A., Urbanowicz, I., De Climens, A. R., Tourneur, Y., Chien, W. W., Catallo, R., Salles, G., et al. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2008.00448.x · Cited by 37
KATHPALIA, V. P., Mussak, E. N., Chow, S., LAM, P. H., Skelley, N. W. M., Time, M., Markelewicz, R. J., Kanduc, D., Lomas, L., Xiang, Z., et al. (2006) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2006.00075.x · Cited by 46
Telomere length variation and maintenance in hepatocarcinogenesis
Yokota, T., Suda, T., Igarashi, M., Kuroiwa, T., Waguri, N., Kawai, H., Mita, Y., & Aoyagi, Y. (2003) · Cancer · doi:10.1002/cncr.11428 · Cited by 39
“Telomeric repeat binding factor 1 (TRF1), one of the telomere-repeat binding factor proteins, shortens telomeres by inhibiting telomerase activity due to stabilization of the telomere structure.(16) Although shortening and lengthening processes have been described, the relationship between telomere length and these re…”
BackgroundRole of telomeres in vascular senescence
Minamino, T., & Komuro, I. (2007) · Frontiers in bioscience · doi:10.2741/2902 · Cited by 40
“TRF1 was originally reported to be mainly involved in the regulation of telomere length (49), whereas TRF2 was implicated in protecting chromosome ends (50).”
BackgroundLong telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk
Llorca-Cardeñosa, M. J., Peña-Chilet, M., Mayor, M., Gómez‐Fernández, C., Casado, B., Martín‐González, M., Carretero, G., Lluch, A. M., Martínez‐Cadenas, C., Ibarrola‐Villava, M., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.09.017 · Cited by 42
“Specifically, the TERT gene encodes for the telomerase enzyme, the TRF1 gene gives a protein that acts as a negative-modulator of TERT activity [3,4] and the CLPTM1L gene product seems to participate in TERT regulation through some regions in the 30 end, called the TERT-CLPTM1L locus [5].”
BackgroundPatel, T., Vasan, R., Gupta, D., Patel, J., & Trivedi, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.8.3085 · Cited by 39
Uysal, F., Kosebent, E. G., Toru, H. S., & Öztürk, S. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01932-1 · Cited by 40
“While the long-term overexpression of TRF1 results in progressive telomere shortening, a lack of TRF1 leads to telomere elongation [5].”
BackgroundTelomere length regulation during cloning, embryogenesis and ageing
Schaetzlein, S., & Rudolph, K. L. (2004) · Reproduction Fertility and Development · doi:10.1071/rd04112 · Cited by 44
Integrated Nanosensors to Determine Levels and Functional Activity of Human Telomerase
Pérez, J. M. S., Grimm, J., Josephson, L., & Weissleder, R. (2008) · Neoplasia · doi:10.1593/neo.08350 · Cited by 41
“08350 Introduction Human telomerase (hTERT) is a ribonucleoprotein reverse transcriptase that catalyzes the addition of telomeric repeat units (TTAGGG) to the telomere’s end of each chromosome [1,2].”
BackgroundInvolvement of the telomeric protein Pin2/TRF1 in the regulation of the mitotic spindle
Nakamura, M., Zhou, X. Z., Kishi, S., & Lu, K. P. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02363-3 · Cited by 45
King, T. J., Fukushima, L. H., Yasui, Y., Lampe, P. D., & Bertram, J. S. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10071 · Cited by 38
“The HTC75 tetracycline-responsive transactivator (tTA)-expressing cell line (hereafter referred to as HT-P) was a generous gift from T. de Lange (Rockefeller University, New York [14]).”
BackgroundInfluentialTelomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy
Aguennouz, M., Vita, G. L., Messina, S., Cama, A., Lanzano, N., Ciranni, A., Rodolico, C., Giorgio, R. M. D., & Vita, G. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.008 · Cited by 39
“…with arsenic trioxide, hich generates reactive oxygen species and oxidative stress, auses upregulation of TRF1 and TRF2 (Zhang et al., 2005). ccumulation of TRF1 at chromosome ends inhibits telomre elongation (van Steensel and de Lange, 1997), most likely ontributing to satellite cell senescence.”
BackgroundSaito, K., Yagihashi, A., Nasu, S., Izawa, Y., Nakamura, M., Kobayashi, D., Tsuji, N., & Watanabe, N. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02166.x · Cited by 39
Yang, S. W., Kim, D. H., Lee, J. J., Chun, Y. J., Lee, J.-H., Kim, Y. J., Chung, I. K., & Kim, W. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209973200 · Cited by 38
The evolution of metazoan shelterin
Myler, L. R., Kinzig, C. G., Sasi, N. K., Zakusilo, G., Cai, S. W., & de Lange, T. (2021) · Genes & Development · doi:10.1101/gad.348835.121 · Cited by 44
Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives
Li, Y., Tong, Y., & Wong, Y. H. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1066-1 · Cited by 37
Snail1 transcription factor controls telomere transcription and integrity
Mazzolini, R., Gonzàlez, N., García-Garijo, A., Millanes‐Romero, A., Peiró, S., Smith, S. H., de Herreros, A. G., & Canudas, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx958 · Cited by 37
Song, H., Li, Y., Chen, G., Xing, Z., Zhao, J., Yokoyama, K. K., Li, T., & Zhao, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.166 · Cited by 37
Delgado, J.-P., Parouchev, A., Allain, J.-É., Pennarun, G., Gauthier, L., Dutrillaux, A., Dutrillaux, B., Santo, J. P. D., Capron, F., Boussin, F. D., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208089 · Cited by 38
Allsopp, R. C., Cheshier, S., & Weissman, I. L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021003 · Cited by 37
“Overexpression of TRF1 or inhibition of its normal association with telomeric chromatin leads to a decrease or increase in telomere length, respectively ( 46 ).”
BackgroundZaffaroni, N., Villa, R., Pastorino, U., Cirincione, R., Incarbone, M., Alloisio, M., Curto, M., Pilotti, S., & Daidone, M. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1293 · Cited by 41
Telomerase and Telomeres: From Basic Biology to Cancer Treatment
Helder, M. N., Wisman, G. B. A., & van der Zee, A. G. J. (2002) · Cancer Investigation · doi:10.1081/cnv-120000370 · Cited by 41
“Targeting RNA for Degradation with a (20-50)Oligoadenylate-Antisense Chimera.”
BackgroundTelomere protein complexes and interactions with telomerase in telomere maintenance
Pinto, A. R., Li, H., Nicholls, C., & Liu, J. (2010) · Frontiers in bioscience · doi:10.2741/3683 · Cited by 41
“It is possible that the shelterin and DNA-PK complexes perform a housekeeping role on telomere duplexes, while the MRN and telomerase complexes are critical for telomere maintenance in damaged and short telomeres, respectively.”
BackgroundInfluentialp300-mediated acetylation of TRF2 is required for maintaining functional telomeres
Her, Y. R., & Chung, I. K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1354 · Cited by 39
Kimura, T., Kawai, K., Fujitsuka, M., & Majima, T. (2004) · Chemical Communications · doi:10.1039/b403913k · Cited by 36
Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation
Krupp, G., Klapper, W., & Parwaresch, R. M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000708 · Cited by 42
Telomere Dynamics in a Human Cancer Cell Line
Sprung, C. N., Sabatier, L., & Murnane, J. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4293 · Cited by 37
Telomere instability in a human cancer cell line
Sprung, C. N., Afshar, G., Chavez, E. A., Lansdorp, P. M., Sabatier, L., & Murnane, J. P. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00115-3 · Cited by 38
Investigating the role of the Est3 protein in yeast telomere replication
Lee, J., Mandell, E. K., Rao, T., Wuttke, D. S., & Lundblad, V. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1173 · Cited by 36
Cao, D., Zhao, J., Nguyan, L. N., Nguyen, L. N., Khanal, S., Dang, X., Schank, M., Thakuri, B. K. C., Wu, X. Y., Morrison, Z. D., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01152 · Cited by 37
Telomerase and Telomeres in Endometrial Cancer
Alnafakh, R., Adishesh, M., Button, L., Saretzki, G. C., & Hapangama, D. K. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00344 · Cited by 64
Telomerase, immortality and cancer
Krupp, G., Bonatz, G., & Parwaresch, R. M. (2000) · Biotechnology annual review · doi:10.1016/s1387-2656(00)06020-8 · Cited by 39
Nair‐Shalliker, V., Dhillon, V. S., Clements, M., Armstrong, B. K., & Fenech, M. F. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.04.001 · Cited by 38
Iachettini, S., Stevens, M. F. G., Frigerio, M., Hummersone, M., Hutchinson, I. S., Garner, T. P., Searle, M. S., Wilson, W. D., Munde, M. M., Nanjunda, R. K., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-68 · Cited by 39
The yeast telomere length regulator TEL2 encodes a protein that binds to telomeric DNA
Kota, R. S., & Runge, K. W. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.6.1528 · Cited by 40
Telomerase in endocrine and endocrine-dependent tumors
Orlando, C., & Gelmini, S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00101-7 · Cited by 35
TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells
Okabe, J., Eguchi, A., Masago, A., Hayakawa, T., & Nakanishi, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2639 · Cited by 37
Incles, C. M., Schultes, C. M., Kèlland, L. R., & Neidle, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1101 · Cited by 35
Fang, D.-C. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i4.522 · Cited by 35
Metadata
- Authors
- van Steensel, B., & de Lange, T.
- Venue
- Nature
- Published
- 1997-02
- Volume
- 385
- Issue
- 6618
- Pages
- 740-743
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086992094
- Semantic Scholar
- 080771c5a8e8b8bc6d55561a31326094194412ea
- Cited by
- 1,219
- References
- 30
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 26 · 2023: 27 · 2022: 13 · 2021: 35 · 2020: 25 · 2019: 25 · 2018: 28 · 2017: 32 · 2016: 30 · 2015: 28 · 2014: 44 · 2013: 37 · 2012: 32
- FWCI
- 43.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- TRF1, telomere length regulation, telomerase, telomere shortening, telomere elongation, telomere binding, negative feedback loop, cancer cells, immortalized cells, TTAGGG repeats
- MeSH terms
- DNA-Binding Proteins, Feedback, Genes, Dominant, HeLa Cells, Humans, Mutation, Recombinant Proteins, Tumor Cells, Cultured, Telomere, Telomerase, Telomeric Repeat Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.